Future of the Microbiome

  • March 23, 2021 - March 25, 2021
  • Virtual Conference

Biomica is delighted to participate at “Future of the Microbiome virtual conference” .
Dr. Shiri Meshner, VP R&D of Biomica, will be participating in the panel discussion: “Future of Live Biotherapeutic Products: Challenges and opportunities in science and regulation”.
Check out the full schedule and register at: www.futureofmicrobiome.com

Back to all News

Highlighted News About Biomica

May 23, 2024

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

Preliminary Phase 1 results show promising trends for BMC128 in combination with nivolumab in refractory cancer patients. Data will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting REHOVOT, Israel, May 23, 2024. Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: […]

Read More